H. Jick, D. Slone, B. Westerholm, W. Inman, M. Vessey et al., VENOUS THROMBOEMBOLIC DISEASE AND ABO BLOOD TYPE. A COOPERATIVE STUDY, Obstetrical & Gynecological Survey, vol.24, issue.9, pp.539-581, 1969.
DOI : 10.1097/00006254-196909000-00009

J. Wautrecht, C. Galle, S. Motte, J. Dereume, and M. Dramaix, The role of ABO blood groups in the incidence of deep vein thrombosis, Thromb Haemost, vol.79, pp.688-697, 1998.

I. Vague, ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden, Thromb Haemost, vol.83, pp.630-631, 2000.

V. Morelli, M. De-visser, N. Van-tilburg, H. Vos, J. Eikenboom et al., ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens, Thrombosis and Haemostasis, vol.97, pp.534-575, 2007.
DOI : 10.1160/TH06-09-0549

I. Tirado, M. J. Soria, J. Oliver, A. Martinez-sanchez, E. Vallve et al., The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism, Thrombosis and Haemostasis, vol.93, pp.468-74, 2005.
DOI : 10.1160/TH04-04-0251

B. Mercier, E. Oger, L. Gal, G. Mottier, D. Ferec et al., Phenotypic but not allelic ABO blood group association with risk of venous thrombosis, Thromb Haemost, vol.93, pp.388-397, 2005.
URL : https://hal.archives-ouvertes.fr/hal-00722045

V. Morelli, D. Visser, M. Vos, H. Bertina, R. Rosendaal et al., ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden, Journal of Thrombosis and Haemostasis, vol.76, issue.1, pp.183-188, 2005.
DOI : 10.1016/S0140-6736(94)90286-0

T. Ohira, M. Cushman, M. Tsai, Y. Zhang, S. Heckbert et al., ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE), Journal of Thrombosis and Haemostasis, vol.10, issue.7, pp.1455-61, 2007.
DOI : 10.1111/j.1538-7836.2004.01071.x

P. Scarabin, E. Oger, and G. Plu-bureau, Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk, The Lancet, vol.362, issue.9382, pp.428-460, 2003.
DOI : 10.1016/S0140-6736(03)14066-4
URL : https://hal.archives-ouvertes.fr/hal-01026273

M. Canonico, E. Oger, G. Plu-bureau, J. Conard, G. Meyer et al., Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: The ESTHER Study, Circulation, vol.115, issue.7, pp.840-845, 2007.
DOI : 10.1161/CIRCULATIONAHA.106.642280
URL : https://hal.archives-ouvertes.fr/hal-00688234

G. Meyer, M. Alhenc-gelas, H. Levesque, N. Trillot, M. Barrellier et al., Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration, Circulation, vol.112, pp.3495-500, 2005.

D. Hosmer and S. Lemeshow, Confidence Interval Estimation of Interaction, Epidemiology, vol.3, issue.5, pp.452-458, 1992.
DOI : 10.1097/00001648-199209000-00012

H. Ito, K. Matsuo, T. Saito, K. Hirose, M. Inoue et al., Valid Responses to ABO Blood Type Question in Self-reporting Questionnaire, Asian Pac J Cancer Prev, vol.2, pp.315-317, 2001.